Rightangled successfully raised £50,000

This site uses cookies. By using this site you agree to receiving cookies. View Policy.

1045%

Rightangled is an award-Winning Health Tech company seed-funded by NHS & regulated by Care Quality Commission. Providing home delivered lab-tests for COVID19, DNA testing for health, diet & fitness - with reports from medical, nutrition & exercise professionals. Featured: CNN, Sky News & Telegraph.

Launched COVID-19 test. PHE confirmed assay to be >98% accurate
Featured on CNN, Sky News, LBC, Daily Mail and the Telegraph
Raising working capital to double team size and deliver sales growth
Plans to release mobile app end of 2020 and develop AI system

Idea

Back in 2017 and with a seed fund from NHS England, we built an online platform that enables medical consultants to provide context onto the patients’ DNA results and self-reported health information, all following a vision to change the way healthcare is delivered to our close family members.

Since then, we have grown from strength to strength and have now released a PCR lab-based test for COVID-19, delivered to users and clients' doorstep. The assay's uptake is massive and we have fulfilled bulk orders for clinics, pharmacies, charities and care homes across the UK. We are now receiving quote requests for larger orders in the 100s of thousands from large corporations. Hence, we are now raising working capital to facilitate the delivery on this demand.

Over the past couple of years, we attained a strategic registration with a medical insurance provider, giving Rightangled clear revenue streams within the medical insurance industry as a regulated facility for screening and diagnostic services.

For our next phase, we aim to expand our products, offering finger-blood tests and continue our growth by localising our testing services in multiple countries (USA, UAE and Saudi Arabia). We are also looking to launch our app and create a powerful AI central system to give instant tailored health, diet and fitness advice, based on our users sample resutls and self-reported health information.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

To see the rest of the Rightangled pitch, join now. It's free, quick and easy.

Due to financial regulations, you need to join our community to view the full investment opportunity.

Join

Already registered?
Log in

Investments of this nature carry risks to your capital, including illiquidity, lack of dividends and dilution. Balance risk with a diversified portfolio. Read more. Approved as a financial promotion by Crowdcube Capital Limited, which is authorised and regulated by the Financial Conduct Authority.

Investment opportunities are not offers to the public and investors must be eligible Crowdcube members. Further restrictions and Crowdcube's limitation of liability are set out in the Investor Terms and Conditions. Please seek independent advice as required as Crowdcube does not give investment or tax advice.

Rightangled has been given advance assurance by HMRC that the proposed share issue is likely to qualify for Enterprise Investment Scheme (EIS) tax relief.

Tax relief is available to individuals only, with income tax relief currently set at 30 per cent of the cost of the shares for the tax year in which the investment was made. The tax reliefs can also reduce your Capital Gains Tax bill. Read More.

Availability of tax relief depends on your individual and the company’s ongoing circumstances and applicable law.

Idea

To see the rest of the Rightangled pitch, join now. It's free, quick and easy.

Risk warning

Investing

Raising

About us

Legal